Tesamorelin 10 mg Certificate of Analysis Batch APL-TES10-2608-03

Tesamorelin 10 mg from batch APL-TES10-2608-03 was analysed on 20 August 2026 and measured 98.7% purity by HPLC / Mass Spectrometry, passing all 5 release tests.

Purity: 98.7%
Result: All 5 tests passed
Tested: 20 August 2026
Method: HPLC / Mass Spectrometry
Net content: 10.16 mg

Independent verification

Tesamorelin 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.04% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-TES5-2608-01, net content 5.38 mg, verification code OZ-HPLCMS-JKJ3; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 24 August 2026, verification code OZ-ENDOTX-1APL.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Third-Party Purity COA (PDF, opens in a new tab)99.04% purity by UPLC-MS/MS · net content 5.38 mg Analysed 27 August 2026 Verification code OZ-HPLCMS-JKJ3
Third-Party Endotoxin Test (PDF, opens in a new tab)Bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL Analysed 24 August 2026 Verification code OZ-ENDOTX-1APL

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 2

Certificate of Analysis Tesamorelin 10 mg Batch APL-TES10-2608-03

Compound: Tesamorelin
Lot Number: APL-TES10-2608-03
Analysis Date: 20 August 2026
Method: HPLC / Mass Spectrometry
Purity: 98.7%
Net Content: 10.16 mg

CAS Number: 218949-48-5
Formula: C221H366N72O67S
Molecular Weight: 5135.8 g/mol
Form: Lyophilised Powder
Manufactured: August 2026
Issued: 21 August 2026
Document ID: APL-COA-TES10-2608-03
Verification Code: Batch traceable

SequenceYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

Main peak integrated at 98.70% of total area; no single impurity peak exceeds 0.49%.

Peak List

Peaks detected: 5

#	Time (min)	Area	% Area	Identification
1	3.810	25,920	0.360	—
2	4.070	35,280	0.490	—
3	4.280	7,106,400	98.700	Tesamorelin
4	4.820	20,160	0.280	—
5	6.190	12,240	0.170	—

Analytical Results

Test	Specification	Result	Status
Appearance	White/Off-White Lyophilised Powder	Conforms	PASS
Identity (MS)	Confirmed	Confirmed	PASS
Purity (HPLC)	≥98.0%	98.70%	PASS
Peptide Content	95–105%	97.6%	PASS
Endotoxins	<0.5 EU/mg	<0.15 EU/mg	PASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 2

Tesamorelin 10 mg

CAS Number: 218949-48-5

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 20 August 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
857	856.97	1.2
1028	1028.17	2.6
1285	1284.96	1.4

Detection assignment: Tesamorelin

Collected Mass Spectrum

Intensity ×10⁷

Verification Protocol

Identity confirmed by mass spectrometry against the expected ion channels.
Purity measured by HPLC as peak area against all integrated impurity peaks.
Batch traceability: this document reports the lot number printed on the vial.
Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View Tesamorelin in the catalogue How to read this certificate